H-y S. Chan

Hong Kong, HCW, Hong Kong Special Administrative Region

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Automated real-time detection of drug-resistant Mycobacterium tuberculosis on a lab-on-a-disc by Recombinase Polymerase Amplification.

Automated real-time detection of drug-resistant Mycobacterium tuberculosis on a lab-on-a-disc by Recombinase Polymerase Amplification.

Journal: Analytical biochemistry

Published: July 21, 2017

Significant positive association of endotoxemia with histological severity in 237 patients with non-alcoholic fatty liver disease.

Significant positive association of endotoxemia with histological severity in 237 patients with non-alcoholic fatty liver disease.

Journal: Alimentary pharmacology & therapeutics

Published: January 09, 2017

Liver fibrosis and fatty liver in Asian HIV-infected patients.

Liver fibrosis and fatty liver in Asian HIV-infected patients.

Journal: Alimentary pharmacology & therapeutics

Published: March 04, 2016

Serum interferon-inducible protein 10 levels predict hepatitis B s antigen seroclearance in patients with chronic hepatitis B.

Serum interferon-inducible protein 10 levels predict hepatitis B s antigen seroclearance in patients with chronic hepatitis B.

Journal: Alimentary pharmacology & therapeutics

Published: August 06, 2015

Bacterial endotoxin and non-alcoholic fatty liver disease in the general population: a prospective cohort study.

Bacterial endotoxin and non-alcoholic fatty liver disease in the general population: a prospective cohort study.

Journal: Alimentary pharmacology & therapeutics

Published: May 19, 2015

Efficacy of tenofovir switch therapy for nucleos(t)ide-experienced patients with chronic hepatitis B.

Efficacy of tenofovir switch therapy for nucleos(t)ide-experienced patients with chronic hepatitis B.

Journal: Alimentary pharmacology & therapeutics

Published: September 18, 2014

Coincidental metabolic syndrome increases the risk of liver fibrosis progression in patients with chronic hepatitis B--a prospective cohort study with paired transient elastography examinations.

Coincidental metabolic syndrome increases the risk of liver fibrosis progression in patients with chronic hepatitis B--a prospective cohort study with paired transient elastography examinations.

Journal: Alimentary pharmacology & therapeutics

Published: December 18, 2013

PNPLA3 gene polymorphism accounts for fatty liver in community subjects without metabolic syndrome.

PNPLA3 gene polymorphism accounts for fatty liver in community subjects without metabolic syndrome.

Journal: Alimentary pharmacology & therapeutics

Published: July 30, 2013

Non-invasive algorithm of enhanced liver fibrosis and liver stiffness measurement with transient elastography for advanced liver fibrosis in chronic hepatitis B.

Non-invasive algorithm of enhanced liver fibrosis and liver stiffness measurement with transient elastography for advanced liver fibrosis in chronic hepatitis B.

Journal: Alimentary pharmacology & therapeutics

Published: July 28, 2013

Assessment of non-alcoholic fatty liver disease using serum total cell death and apoptosis markers.

Assessment of non-alcoholic fatty liver disease using serum total cell death and apoptosis markers.

Journal: Alimentary pharmacology & therapeutics

Published: June 15, 2012

Undetectable HBV DNA at month 12 of entecavir treatment predicts maintained viral suppression and HBeAg-seroconversion in chronic hepatitis B patients at 3 years.

Undetectable HBV DNA at month 12 of entecavir treatment predicts maintained viral suppression and HBeAg-seroconversion in chronic hepatitis B patients at 3 years.

Journal: Alimentary pharmacology & therapeutics

Published: January 26, 2012

Showing 1-11 of 11

Last Updated: 09/26/2026